Form 4: Surgery Partners Executive Acquires Shares Following Performance Vesting

Marissa Brittenham, Chief Strategy Officer of Surgery Partners, acquired 25,110 shares of common stock on January 31, 2025, following the vesting of performance stock units.

Summary

• On January 31, 2025, Marissa Brittenham, Chief Strategy Officer of Surgery Partners, acquired 25,110 shares of common stock.
• The acquisition was a result of performance stock units vesting based on performance criteria for the three-year period ending December 31, 2024.
• The shares vested immediately upon certification by the Board on January 31, 2025.
• Following the transaction, Brittenham directly owns 64,878 shares of Surgery Partners common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The vesting of performance stock units suggests the company met certain performance goals, which is a positive indicator. However, it's a routine transaction and doesn't necessarily indicate a major shift in the company's outlook.

Positives

• The vesting of performance stock units suggests that the company met certain performance goals over the three-year period ending December 31, 2024.
• Executive ownership aligns management's interests with those of shareholders.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders. This filing indicates that a key executive received shares as part of their compensation package, which is a common practice in publicly traded companies.

Stakeholder Impact

• The transaction increases the executive's stake in the company, aligning their interests with shareholders.
• The vesting of performance stock units may have a minor dilutive effect on existing shareholders.

Key Dates